Transplantation of isolated islets of Langerhans in diabetic dogs. III. Donor selection by mixed lymphocyte reaction and immunosuppressive treatment. 1979

D Lorenz, and H Lippert, and E Panzig, and H Köhler, and G Koch, and W Tietz, and H J Hahn, and A Dorn, and V Worm, and M Ziegler

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D010180 Pancreatectomy Surgical removal of the pancreas. (Dorland, 28th ed) Pancreatectomies
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014181 Transplantation Immunology A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection. Immunology, Transplantation

Related Publications

D Lorenz, and H Lippert, and E Panzig, and H Köhler, and G Koch, and W Tietz, and H J Hahn, and A Dorn, and V Worm, and M Ziegler
January 1977, Acta physiologica latino americana,
D Lorenz, and H Lippert, and E Panzig, and H Köhler, and G Koch, and W Tietz, and H J Hahn, and A Dorn, and V Worm, and M Ziegler
December 2011, Current opinion in organ transplantation,
D Lorenz, and H Lippert, and E Panzig, and H Köhler, and G Koch, and W Tietz, and H J Hahn, and A Dorn, and V Worm, and M Ziegler
January 1976, Medecine & chirurgie digestives,
D Lorenz, and H Lippert, and E Panzig, and H Köhler, and G Koch, and W Tietz, and H J Hahn, and A Dorn, and V Worm, and M Ziegler
February 1974, The Journal of urology,
D Lorenz, and H Lippert, and E Panzig, and H Köhler, and G Koch, and W Tietz, and H J Hahn, and A Dorn, and V Worm, and M Ziegler
June 1965, Lyon medical,
D Lorenz, and H Lippert, and E Panzig, and H Köhler, and G Koch, and W Tietz, and H J Hahn, and A Dorn, and V Worm, and M Ziegler
January 1975, Surgery,
D Lorenz, and H Lippert, and E Panzig, and H Köhler, and G Koch, and W Tietz, and H J Hahn, and A Dorn, and V Worm, and M Ziegler
January 1975, Acta diabetologica latina,
D Lorenz, and H Lippert, and E Panzig, and H Köhler, and G Koch, and W Tietz, and H J Hahn, and A Dorn, and V Worm, and M Ziegler
July 1984, Diabetologia,
D Lorenz, and H Lippert, and E Panzig, and H Köhler, and G Koch, and W Tietz, and H J Hahn, and A Dorn, and V Worm, and M Ziegler
March 1977, Transplantation proceedings,
D Lorenz, and H Lippert, and E Panzig, and H Köhler, and G Koch, and W Tietz, and H J Hahn, and A Dorn, and V Worm, and M Ziegler
June 1992, Transplantation proceedings,
Copied contents to your clipboard!